Eyebright Medical Technology (Beijing) Co., Ltd. (688050.SS)
CNY 89.86
(-0.38%)
CNY 89.86
(-0.38%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 390.05 Million CNY | 139.61% |
| 2022 | 162.79 Million CNY | 5.13% |
| 2021 | 154.84 Million CNY | 5482.79% |
| 2020 | 2.77 Million CNY | 210.1% |
| 2019 | 894.45 Thousand CNY | -88.4% |
| 2018 | 7.71 Million CNY | -81.53% |
| 2017 | 41.75 Million CNY | 132.96% |
| 2016 | 17.92 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 747.85 Million CNY | 84.29% |
| 2024 Q1 | 405.79 Million CNY | 4.03% |
| 2023 Q4 | 390.05 Million CNY | 126.31% |
| 2023 FY | 390.05 Million CNY | 139.61% |
| 2023 Q2 | 171.16 Million CNY | 5.31% |
| 2023 Q1 | 162.52 Million CNY | -0.16% |
| 2023 Q3 | 172.35 Million CNY | 0.69% |
| 2022 Q3 | 164.18 Million CNY | -0.36% |
| 2022 Q1 | 156.58 Million CNY | 1.12% |
| 2022 FY | 162.79 Million CNY | 5.13% |
| 2022 Q4 | 162.79 Million CNY | -0.85% |
| 2022 Q2 | 164.78 Million CNY | 5.24% |
| 2021 Q2 | 40.28 Million CNY | 1592.01% |
| 2021 FY | 154.84 Million CNY | 5482.79% |
| 2021 Q1 | 2.38 Million CNY | -14.16% |
| 2021 Q4 | 154.84 Million CNY | 53.42% |
| 2021 Q3 | 100.93 Million CNY | 150.55% |
| 2020 FY | 2.77 Million CNY | 210.1% |
| 2020 Q4 | 2.77 Million CNY | 0.0% |
| 2020 Q3 | - CNY | 0.0% |
| 2020 Q2 | - CNY | -100.0% |
| 2020 Q1 | 450.44 Thousand CNY | -49.64% |
| 2019 FY | 894.45 Thousand CNY | -88.4% |
| 2019 Q2 | 3.72 Million CNY | 0.0% |
| 2019 Q3 | - CNY | -100.0% |
| 2019 Q4 | 894.45 Thousand CNY | 0.0% |
| 2019 Q1 | - CNY | -100.0% |
| 2018 FY | 7.71 Million CNY | -81.53% |
| 2018 Q4 | 7.71 Million CNY | 0.0% |
| 2017 FY | 41.75 Million CNY | 132.96% |
| 2016 FY | 17.92 Million CNY | 0.0% |